KRAS and neoplasm: KRAS-induced high calcium and integrin-binding protein 1 (CIB1) expression also alters the metabolic profile, leading to increased glycolysis metabolism, oxidative phosphorylation, and hypoxia pathway activation, which promotes tumor development (Fig. 5).